{
    "Allele Frequency": "0.017", 
    "Build 37 Chromosome": "chr11", 
    "Build 37 Position": "113283484", 
    "Build 37 Variant Allele": "C", 
    "Build37 coordinates:": [], 
    "Clinical Importance": "Low", 
    "Condition Tags": [
        "Mental and behavioral"
    ], 
    "Evidence": "Likely", 
    "Gene Symbol": "DRD2", 
    "Impact": "Pathogenic", 
    "Inheritance": "Dominant", 
    "PMID Count": 6, 
    "PMID List": [
        "7907680", 
        "8824240", 
        "9650635", 
        "12707934", 
        "16402354", 
        "17651483"
    ], 
    "Scores": {
        "Case/Control": "4", 
        "Computational": "0", 
        "Familial": "0", 
        "Functional": "2", 
        "Penetrance": "1", 
        "Severity": "4", 
        "Treatability": "4"
    }, 
    "Summary": "Various studies report this variant in a dopamine receptor is associated with increased risk for schizophrenia. Assuming an average 1% chance of schizophrenia in the general population, combined data suggests carriers of this variant have a risk of 1.4% (0.4% increased risk above average).", 
    "URL": "http://evidence.pgp-hms.org/DRD2-S311C", 
    "Variant Name": "DRD2-S311C", 
    "Variant Page": "http://evidence.pgp-hms.org/DRD2-S311C", 
    "dbSNP IDs": [
        "rs1801028"
    ]
}